Submission for OMB Review; Comment Request, 57729-57730 [2018-25053]
Download as PDF
<![CDATA[
57729
Federal Register / Vol. 83, No. 222 / Friday, November 16, 2018 / Notices
(SRAE) Program—National Descriptive
Study
OMB NO.: [NEW]
Description: The Administration for
Children and Families (ACF) proposes a
data collection effort related to the
National Evaluation of the Sexual Risk
Avoidance Education (SRAE) Program—
National Descriptive Study.
The National Descriptive Study (of
the National Evaluation of the SRAE
Program) has multiple components.
This information collection request only
pertains to the Early Implementation
Study, which will provide an early
catalogue of SRAE programs’
implementation. ACF seeks approval to
collect the following information:
—Survey for Use with SRAE grantees.
The purpose of this collection effort is
to conduct surveys with
administrators/program directors in
each of the states/organizations that
received SRAE grants to better
understand what key decisions states/
organizations made regarding the
design of their SRAE-funded
programs and why they made those
decisions.
Interview Guide for Use with SRAE
grantees. The purpose of this collection
effort is to conduct semi-structured
interviews, that follow-on the surveys,
with administrators/program directors
in each of the states/organizations that
received SRAE grants: The interviews
will offer long-answer, qualitative
responses to key questions, to better
understand what key decisions states/
organizations made regarding the
design of their SRAE-funded programs
and why they made those decisions.
Respondents: State level
administrators; Agency administrators;
Organization heads; Project directors
ANNUAL BURDEN ESTIMATES
Total
number of
respondents
Instrument
Survey for SRAE Grantees ..................................................
Interview Guide for SRAE Grantees ....................................
Estimated Total Annual Burden
Hours: 250 hours.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research,
and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. Email
address: OPREinfocollection@
acf.hhs.gov. All requests should be
identified by the title of the information
collection. The Department specifically
requests comments on (a) whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
Annual
number of
respondents
125
125
Number of
responses per
respondent
1
1
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Emily Jabbour,
ACF/OPRE Certifying Officer.
[FR Doc. 2018–24997 Filed 11–15–18; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: National Youth in Transition
Database (NYTD) and Youth Outcomes
Survey.
OMB No.: 0970–0340.
Description: The Foster Care
Independence Act of 1999 (42 U.S.C.
1305 et seq.) as amended by Public Law
106–169 requires State child welfare
agencies to collect and report to the
Administration on Children and
1
1
Average
burden
hours per
response
Annual
burden
hours
1
1
125
125
Families (ACF) data on the
characteristics of youth receiving
independent living services and
information regarding their outcomes.
The regulation implementing the
National Youth in Transition Database,
listed in 45 CFR 1356.80, contains
standard data collection and reporting
requirements for States to meet the law’s
requirements. Additionally, the Family
First Prevention Services Act of 2017
(H.R. 253) further outlines the
expectation of the collection and
reporting of data and outcomes
regarding youth who are in receipt of
independent living services. ACF will
use the information collected under the
regulation to track independent living
services, assess the collective outcomes
of youth, and potentially to evaluate
State performance with regard to those
outcomes consistent with the law’s
mandate.
Respondents: State agencies that
administer the John H. Chafee Foster
Care Independence Program. The U.S.
Virgin Islands have been included in
this request as they are expected to
begin participating in NYTD data
collection efforts during this approval
period.
amozie on DSK3GDR082PROD with NOTICES
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
Data file ............................................................................................................
Youth Outcomes Survey ..................................................................................
VerDate Sep<11>2014
17:19 Nov 15, 2018
Jkt 247001
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
53
16,333
E:\FR\FM\16NON1.SGM
2
1
16NON1
Average
burden hours
per response
1,430
.50
Total burden
hours
151,580
8,167
57730
Federal Register / Vol. 83, No. 222 / Friday, November 16, 2018 / Notices
Estimated Total Annual Burden
Hours: 155,529.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 330
C Street SW, Washington, DC 20201.
Attention Reports Clearance Officer. All
requests should be identified by the title
of the information collection. Email
address: infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget Paperwork
Reduction Project Email: OIRA_
SUBMISSION@OMB.EOP.GOV. Attn:
Desk Officer for the Administration for
Children and Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2018–25053 Filed 11–15–18; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
amozie on DSK3GDR082PROD with NOTICES
[Docket Nos. FDA–2017–M–6970, FDA–
2017–M–6971, FDA–2017–M–6983, FDA–
2017–M–6984, FDA–2017–M–7004, FDA–
2018–M–0411, FDA–2018–M–0528, FDA–
2018–M–0620, FDA–2018–M–0736, FDA–
2018–M–0737, FDA–2018–M–00–0738, FDA–
2018–M–0792, FDA–2018–M–1371, FDA–
2018–M–1215, FDA–2018–M–1237, FDA–
2018–M–1372, FDA–2018–M–1446, FDA–
2018–M–1447, FDA–2018–M–1580, FDA–
2018–M–1581, FDA–2018–M–1634, FDA–
2018–M–1727, FDA–2018–M–1791, FDA–
2018–M–1753, FDA–2018–M–1970, FDA–
2018–M–2118, FDA–2018–M–2119, FDA–
2018–M–2237, FDA–2018–M–2269, FDA–
2018–M–2335, FDA–2018–M–2460, FDA–
2018–M–2461, FDA–2018–M–2462, FDA–
2018–M–2463, FDA–2018–M–2571, FDA–
2018–M–2883, FDA–2018–M–2884, FDA–
2018–M–2885, FDA–2018–M–2886, FDA–
2018–M–2887, FDA–2018–M–2983, FDA–
2018–M–3131, FDA–2018–M–3153, FDA–
2018–M–3212, FDA–2018–M–3503, FDA–
2018–M–3505, and FDA–2018–M–3548]
Medical Devices; Availability of Safety
and Effectiveness Summaries for
Premarket Approval Applications
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
VerDate Sep<11>2014
17:19 Nov 15, 2018
Jkt 247001
The Food and Drug
Administration (FDA) is publishing a
list of premarket approval applications
(PMAs) and humanitarian device
exemption applications (HDEs), that
have been approved. This list is
intended to inform the public of the
availability of safety and effectiveness
summaries of approved PMAs through
the internet and the Agency’s Dockets
Management Staff.
ADDRESSES: You may submit comments
as follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket Nos. FDA–
2017–M–6970, FDA–2017–M–6971,
FDA–2017–M–6983, FDA–2017–M–
6984, FDA–2017–M–7004, FDA–2018–
M–0411, FDA–2018–M–0528, FDA–
2018–M–0620, FDA–2018–M–0736,
FDA–2018–M–0737, FDA–2018–M–00–
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
0738, FDA–2018–M–0792, FDA–2018–
M–1371, FDA–2018–M–1215, FDA–
2018–M–1237, FDA–2018–M–1372,
FDA–2018–M–1446, FDA–2018–M–
1447, FDA–2018–M–1580, FDA–2018–
M–1581, FDA–2018–M–1634, FDA–
2018–M–1727, FDA–2018–M–1791,
FDA–2018–M–1753, FDA–2018–M–
1970, FDA–2018–M–2118, FDA–2018–
M–2119, FDA–2018–M–2237, FDA–
2018–M–2269, FDA–2018–M–2335,
FDA–2018–M–2460, FDA–2018–M–
2461, FDA–2018–M–2462, FDA–2018–
M–2463, FDA–2018–M–2571, FDA–
2018–M–2883, FDA–2018–M–2884,
FDA–2018–M–2885, FDA–2018–M–
2886, FDA–2018–M–2887, FDA–2018–
M–2983, FDA–2018–M–3131, FDA–
2018–M–3153, FDA–2018–M–3212,
FDA–2018–M–3503, FDA–2018–M–
3505, and FDA–2018–M–3548 for
‘‘Medical Devices; Availability of Safety
and Effectiveness Summaries for
Premarket Approval Applications.’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf .
E:\FR\FM\16NON1.SGM
16NON1
]]>Agencies
[Federal Register Volume 83, Number 222 (Friday, November 16, 2018)]
[Notices]
[Pages 57729-57730]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25053]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Comment Request
Title: National Youth in Transition Database (NYTD) and Youth
Outcomes Survey.
OMB No.: 0970-0340.
Description: The Foster Care Independence Act of 1999 (42 U.S.C.
1305 et seq.) as amended by Public Law 106-169 requires State child
welfare agencies to collect and report to the Administration on
Children and Families (ACF) data on the characteristics of youth
receiving independent living services and information regarding their
outcomes. The regulation implementing the National Youth in Transition
Database, listed in 45 CFR 1356.80, contains standard data collection
and reporting requirements for States to meet the law's requirements.
Additionally, the Family First Prevention Services Act of 2017 (H.R.
253) further outlines the expectation of the collection and reporting
of data and outcomes regarding youth who are in receipt of independent
living services. ACF will use the information collected under the
regulation to track independent living services, assess the collective
outcomes of youth, and potentially to evaluate State performance with
regard to those outcomes consistent with the law's mandate.
Respondents: State agencies that administer the John H. Chafee
Foster Care Independence Program. The U.S. Virgin Islands have been
included in this request as they are expected to begin participating in
NYTD data collection efforts during this approval period.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Data file....................................... 53 2 1,430 151,580
Youth Outcomes Survey........................... 16,333 1 .50 8,167
----------------------------------------------------------------------------------------------------------------
[[Page 57730]]
Estimated Total Annual Burden Hours: 155,529.
Additional Information: Copies of the proposed collection may be
obtained by writing to the Administration for Children and Families,
Office of Planning, Research and Evaluation, 330 C Street SW,
Washington, DC 20201. Attention Reports Clearance Officer. All requests
should be identified by the title of the information collection. Email
address: [email protected].
OMB Comment: OMB is required to make a decision concerning the
collection of information between 30 and 60 days after publication of
this document in the Federal Register. Therefore, a comment is best
assured of having its full effect if OMB receives it within 30 days of
publication. Written comments and recommendations for the proposed
information collection should be sent directly to the following: Office
of Management and Budget Paperwork Reduction Project Email:
[email protected]. Attn: Desk Officer for the Administration
for Children and Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2018-25053 Filed 11-15-18; 8:45 am]
BILLING CODE 4184-01-P
